PATENT CLAIM ANALYSIS

Application Number: 15762050
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-09
Patent Classification: ["424", "209100"]

Abstract:
Provided herein are optimized, recombinant influenza HA polypeptides that elicit immune responses. Also provided are compositions and kits comprising the optimized HA polypeptides as well as methods of making and using the optimized HA polypeptides.

Claim (Index 26):
A cell comprising the vector of  claim 22  or  23  or the plurality of vectors of  claim 24  or  25 .

Metadata:
- Claim Count in Document: 18.0
- Percentile: 90.0
- Lexical Diversity: 1.40741
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14388726', '15051991', '15392710', '14377633', '14376689']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7683666865869494
- 35 USC 102 Novelty (BERT): 0.532932154573586
- Combined Prediction Score: 0.7448232333856131
- Mean Citation Score: 368.001672
- Max Citation Score: 375.28708
- Similarity Product: 229.9372252955341

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test